Versor Investments Lp Portfolio Changes in Q3 2026
Versor Investments Lp's portfolio reached a total value of $47.5 million as of June 30, 2026. This analysis highlights key purchases and sales observed during the quarter.
Strategic Portfolio Shifts in Q3
Versor Investments Lp's portfolio saw significant changes during the third quarter of 2026, as evidenced by its holdings data released on June 30. The fund demonstrated a clear focus on acquiring companies within specific sectors while strategically reducing exposure elsewhere.
Major Acquisitions
The most notable activity involved substantial increases in portfolio weight for several key positions:
- Nuvalent Inc (NUVL), a Healthcare company, saw its position fully replenished with 25,850 shares purchased.
- Bio-Techne Corp (TECH) experienced a full buyback of its previous stake in the Healthcare sector.
- Apogee Therapeutics Inc (APGE), another Healthcare holding, was fully restocked with 18,222 shares acquired.
- Catalyst Pharmaceuticals Inc (CPRX) had its entire position rebuilt during the quarter.
- The Industrial sector also saw a significant addition with Unifirst Corp Mass (UNF), which experienced a 330.7% increase in shares held by Versor, adding considerable weight to this part of the portfolio.
Notable Sales and Reduced Exposure
In contrast to these large buys, Versor also divested from certain holdings or scaled back positions:
- Talkspace Inc (TALK), a Healthcare company with significant exposure, saw its stake reduced by 18.43% in terms of share increase change.
- Several other positions were either newly initiated or increased significantly during the quarter:
- Leggett & Platt Inc (LEG), a Consumer Cyclical company, was fully bought in by Versor.
- AES Corp (AES) experienced a substantial increase of 253.51% in shares held.
- Organon & Co (OGN), despite being fully restocked, showed significant growth with an over 370% share increase change.
- NCR Alleos Corp (NATL) saw a massive jump of nearly 250% in shares held by Versor.
- Liveramp Hldgs Inc (RAMP), a Technology company, was fully bought in during the quarter.
Portfolio Concentration and Diversification
Versor's portfolio remains heavily concentrated in Healthcare, accounting for approximately 40.78% of its total value ($19.3 million). Technology follows with a significant allocation of $6.75 million (14.2%), while Industrials and Consumer Cyclical also represent substantial portions.
The fund maintains diversification across various sectors, including Communication Services, Utilities, Financial Services, Energy, Real Estate, and others, though the exact breakdown includes some 'Unknown' allocations worth $3.0 million (6.39%).